FTRE 📈 Fortrea Holdings - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US34965K1079
FTRE: Biopharmaceuticals, Medical Devices, Clinical Trials, Technology Solutions
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. Web URL: https://www.fortrea.com
Additional Sources for FTRE Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FTRE Stock Overview
Market Cap in USD | 1,794m |
Sector | Healthcare |
Industry | Biotechnology |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 2023-07-03 |
FTRE Stock Ratings
Growth 5y | -74.1% |
Fundamental | -44.4% |
Dividend | - |
Rel. Strength Industry | -897 |
Analysts | 3.17/5 |
Fair Price Momentum | 15.90 USD |
Fair Price DCF | 44.51 USD |
FTRE Dividends
No Dividends PaidFTRE Growth Ratios
Growth Correlation 3m | 32.4% |
Growth Correlation 12m | -85.6% |
Growth Correlation 5y | -62.3% |
CAGR 5y | -25.43% |
CAGR/Mean DD 5y | -0.97 |
Sharpe Ratio 12m | -0.74 |
Alpha | -86.30 |
Beta | 1.73 |
Volatility | 75.15% |
Current Volume | 2653.8k |
Average Volume 20d | 1307.3k |
What is the price of FTRE stocks?
As of December 21, 2024, the stock is trading at USD 19.26 with a total of 2,653,832 shares traded.
Over the past week, the price has changed by -3.70%, over one month by +0.57%, over three months by -19.41% and over the past year by -40.99%.
As of December 21, 2024, the stock is trading at USD 19.26 with a total of 2,653,832 shares traded.
Over the past week, the price has changed by -3.70%, over one month by +0.57%, over three months by -19.41% and over the past year by -40.99%.
Is Fortrea Holdings a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Fortrea Holdings (NASDAQ:FTRE) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.39 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FTRE as of December 2024 is 15.90. This means that FTRE is currently overvalued and has a potential downside of -17.45%.
Probably not. Based on ValueRay Fundamental Analyses, Fortrea Holdings (NASDAQ:FTRE) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.39 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FTRE as of December 2024 is 15.90. This means that FTRE is currently overvalued and has a potential downside of -17.45%.
Is FTRE a buy, sell or hold?
Fortrea Holdings has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold FTRE.
Fortrea Holdings has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold FTRE.
- Strong Buy: 1
- Buy: 1
- Hold: 9
- Sell: 1
- Strong Sell: 0
What are the forecast for FTRE stock price target?
According to ValueRays Forecast Model, FTRE Fortrea Holdings will be worth about 17.2 in December 2025. The stock is currently trading at 19.26. This means that the stock has a potential downside of -10.85%.
According to ValueRays Forecast Model, FTRE Fortrea Holdings will be worth about 17.2 in December 2025. The stock is currently trading at 19.26. This means that the stock has a potential downside of -10.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 23.4 | 21.5% |
Analysts Target Price | 28.7 | 48.9% |
ValueRay Target Price | 17.2 | -10.9% |